SCHEMBL23957137

SCHEMBL23957137

CNC(C)(C)CC(C)C1CC(=O)c2ccccc2O1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.43
ADORA3 P0DMS8 3/20 0.43
AR P10275 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP19A1 P11511 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
HSD11B1 P28845 1/20 0.39
AKR1C3 P42330 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
AXL P30530 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
ABCB1 P08183 2/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11376090 0.80 MAOB (0.50) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL13690008 0.78 MAOB (0.48) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL6836628 0.76 MAOB (0.56) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL11165877 0.72 MAOB (0.50) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL11387674 0.70 MAOB (0.56) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL14992983 0.70 MAOB (0.56) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL11167408 0.68 MAOB (0.47) MAOBADORA3ARKDM4ECYP19A1
Dimethylamine SCHEMBL11174999 0.68 MAOB (0.56) MAOBADORA3ARKDM4ECYP19A1
Dimethylamine SCHEMBL11167355 0.67 MAOB (0.51) MAOBADORA3ARKDM4ECYP19A1
SCHEMBL10344116 0.66 MAOB (0.62) MAOBADORA3ARKDM4ECYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 MAOB 1806/4885ADORA3 65/4885AR 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.